![]() | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H16FNO |
| Molar mass | 209.264 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3-Fluoro-N-ethylbuphedrone (3F-NEB) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug.1 It was first identified in Sweden in 2021.23
References
References
- Pain S, Nadal-Gratacós N, De Macedo M, Lardeux V, Mata S, Puigseslloses P, et al. (February 2026). "Neurochemical and behavioral evidence of high abuse liability of 3F-NEB, a novel synthetic cathinone". European Journal of Pharmacology. 1015 178570. doi:10.1016/j.ejphar.2026.178570. hdl:20.500.14342/5980. PMID 41554370.
- European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/396103. ISBN 978-92-9497-737-3.
- Kuropka P, Zawadzki M, Szpot P (September 2022). "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology. 41 (1): 25–46. doi:10.1007/s11419-022-00639-5. PMC 9476408. PMID 36124107.
